Elizabeth Hurlburt, Chief Operating Officer of CorMedix Inc. ($CRMD), sold shares on the open market twice in the last 365 days for a total of about $712,000. Her most recent sale occurred on September 11, 2025. These CRMD insider sales rank 5,698th among 11,678 individual insiders in our database, where the average sale totals $8.6 million across about 6.4 transactions. Hurlburt made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | A | Common Stock | 36006 | $0.00 | 278,539.0000 | 80,308 | 14.85% | 44.84% |
| Jan. 23, 2026 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 10778 | $7.27 | 242,533.0000 | 80,308 | 4.25% | 13.42% |
| Jan. 23, 2026 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | A | Common Stock | 93010 | $0.00 | 253,311.0000 | 80,308 | 58.02% | 100.00% |
| Jan. 12, 2026 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 5794 | $7.15 | 160,301.0000 | 80,308 | 3.49% | 7.21% |
| Jan. 2, 2026 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 10895 | $12.16 | 166,095.0000 | 80,308 | 6.16% | 13.57% |
| Sept. 9, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | S | Common Stock | 12876 | $13.51 | 176,990.0000 | 71,918,624 | 6.78% | 0.02% |
| Sept. 11, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | M | Common Stock | 41121 | $1.45 | 218,111.0000 | 71,918,624 | 23.23% | 0.06% |
| Sept. 9, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | M | Common Stock | 12876 | $1.45 | 189,866.0000 | 71,918,624 | 7.27% | 0.02% |
| Sept. 11, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | M | Stock Option (Right to Buy Common Stock) | 41121 | $0.00 | 0.0000 | 71,918,624 | 100.00% | 0.06% |
| Sept. 9, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | M | Stock Option (Right to Buy Common Stock) | 12876 | $0.00 | 41,121.0000 | 71,918,624 | 23.85% | 0.02% |
| Sept. 11, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | S | Common Stock | 41121 | $13.08 | 176,990.0000 | 71,918,624 | 18.85% | 0.06% |
| Aug. 29, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | F | Common Stock | 8424 | $14.83 | 176,990.0000 | 71,918,624 | 4.54% | 0.01% |
| Aug. 29, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | Chief Operating Officer | A | Common Stock | 69686 | $0.00 | 185,414.0000 | 71,918,624 | 60.22% | 0.10% |
| Jan. 10, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | F | Common Stock | 5790 | $11.19 | 115,728.0000 | 58,872 | 4.76% | 9.83% |
| Jan. 2, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | A | Common Stock | 87500 | $0.00 | 132,897.0000 | 58,872 | 192.74% | 100.00% |
| Jan. 2, 2025 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | F | Common Stock | 11378 | $8.22 | 121,519.0000 | 58,872 | 8.56% | 19.33% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | S | Common Stock | 140027 | $11.18 | 230,821.0000 | 58,825,221 | 37.76% | 0.24% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 25000 | $0.00 | 75,000.0000 | 58,825,221 | 25.00% | 0.04% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Common Stock | 9888 | $5.63 | 108,854.0000 | 58,825,221 | 9.99% | 0.02% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Common Stock | 8169 | $8.30 | 98,966.0000 | 58,825,221 | 9.00% | 0.01% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Common Stock | 3 | $1.45 | 90,797.0000 | 58,825,221 | 0.00% | 0.00% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 34467 | $0.00 | 3,033.0000 | 58,825,221 | 91.91% | 0.06% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 9888 | $0.00 | 27,612.0000 | 58,825,221 | 26.37% | 0.02% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 8169 | $0.00 | 12,711.0000 | 58,825,221 | 39.12% | 0.01% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 3 | $0.00 | 53,997.0000 | 58,825,221 | 0.01% | 0.00% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Stock Option (Right to Buy Common Stock) | 62500 | $0.00 | 62,500.0000 | 58,825,221 | 50.00% | 0.11% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Common Stock | 25000 | $3.47 | 230,821.0000 | 58,825,221 | 12.15% | 0.04% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Common Stock | 62500 | $4.43 | 205,821.0000 | 58,825,221 | 43.61% | 0.11% |
| Nov. 14, 2024 | CorMedix Inc. | $CRMD | Hurlburt Elizabeth | EVP | M | Common Stock | 34467 | $4.08 | 143,321.0000 | 58,825,221 | 31.66% | 0.06% |
| Jan. 12, 2024 | CorMedix Inc. | $CRMD | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A | Stock Option (Right to Buy Common Stock) | 100000 | $0.00 | 100,000.0000 | 50,902,931 | 9999.99% | 0.20% |
| Jan. 12, 2024 | CorMedix Inc. | $CRMD | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | A | Common Stock | 50000 | $0.00 | 58,000.0000 | 50,902,931 | 625.00% | 0.10% |
| Jan. 12, 2024 | CorMedix Inc. | $CRMD | Masson-Hurlburt Elizabeth | EVP, Head of Clinical Ops. | F | Common Stock | 4603 | $3.47 | 53,397.0000 | 50,902,931 | 7.94% | 0.01% |